Long-term study of the frequency of Escherichia coli and Klebsiella pneumoniae isolates producing extended-spectrum β-lactamases L. Romero, L. López,

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Extended-spectrum β-lactamase producing Klebsiella spp

Bloodstream infections among carriers of carbapenem-resistant Klebsiella pneumoniae: etiology, incidence and predictors S. Amit, H. Mishali, T. Kotlovsky,

R. Cantón, A. Novais, A. Valverde, E. Machado, L. Peixe, F. Baquero, T

Gut bacterial microbiota and obesity

Migrant health—a cause for concern?

Evolution of extended-spectrum β-lactamases by mutation

Extended-spectrum and CMY-type b-lactamase-producing Escherichia coli in clinical samples and retail meat from Pittsburgh, USA and Seville, Spain Y.

Defining an extended-spectrum β-lactamase

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

A.K. Reddy, P. Garg, I. Kaur Clinical Microbiology and Infection

Evaluation of VITEK 2 for analysis of Enterobacteriaceae using the Advanced Expert System (AES) versus interpretive susceptibility guidelines used at.

Gentamicin susceptibility in Escherichia coli related to the genetic background: problems with breakpoints L. Jakobsen, D. Sandvang, V.F. Jensen, A.M.

M. Giannella, B. Pinilla, J. A. Capdevila, J. Martínez Alarcón, P

Molecular and phenotypic profiling of sorbitol-fermenting Escherichia coli O157:H− human isolates from Finland M. Eklund, M. Bielaszewska, U.-M. Nakari,

Extended-spectrum β-lactamase/AmpC- and carbapenemase-producing Enterobacteriaceae in animals: a threat for humans? J.-Y. Madec, M. Haenni, P. Nordmann,

Is the prevalence of antibiotic-resistant organisms changing in Canadian hospitals? Comparison of point-prevalence survey results in 2010 and 2012 V.

Impact of changes in CLSI and EUCAST breakpoints for susceptibility in bloodstream infections due to extended-spectrum β-lactamase-producing Escherichia.

Klebsiella pneumoniae: development of a mixed population of carbapenem and tigecycline resistance during antimicrobial therapy in a kidney transplant.

Escherichia coli native valve endocarditis

A multicentre analysis of epidemiology of the nosocomial bloodstream infections in Japanese university hospitals M. Nagao Clinical Microbiology and.

Activity of ciprofloxacin and levofloxacin in experimental pneumonia caused by Klebsiella pneumoniae deficient in porins, expressing active efflux and.

Vector control: a cornerstone in the malaria elimination campaign

Pharmacodynamics of doxycycline

Training for the infectious diseases speciality in Norway

G. Höffken Clinical Microbiology and Infection

Laboratory diagnosis and biosafety issues of biological warfare agents

Comparative assessment of inoculum effects on the antimicrobial activity of amoxycillin- clavulanate and piperacillin-tazobactam with extended-spectrum.

Emergence of CTX-M-15 extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolates in Bosnia and Herzegovina A. Dedeic-Ljubovic, M. Hukic,

Control of infections due to extended-spectrum β-lactamase-producing organisms in hospitals and the community R.E. Warren, G. Harvey, R. Carr, D. Ward,

C. Varela, A. Oliver, T.M. Coque, F. Baquero, R. Canton

Four-year epidemiological study of extended-spectrum β-lactamase-producing Enterobacteriaceae in a French teaching hospital L. Gibold, F. Robin, R.-N.

Levofloxacin in the treatment of ventilator-associated pneumonia

R. Bitterman, M. Paul, D. Polak, Y. Geffen

Metagenomics and probiotics

Previously unknown species of Aspergillus

Risk factors for extended-spectrum β-lactamase-producing Escherichia coli urinary tract infection in the community in Denmark: a case–control study M.

Laboratory diagnosis of Clostridium difficile disease

Faecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae is common 12 months after infection and is related to strain factors E.

T.M. File Clinical Microbiology and Infection

Harmonised monitoring of antimicrobial resistance in Salmonella and Campylobacter isolates from food animals in the European Union S. Bronzwaer Clinical.

Antibacterial drug discovery in the 21st century

Bacteraemia caused by third-generation cephalosporin-resistant Escherichia coli in France: prevalence, molecular epidemiology and clinical features A.

Pandemic lineages of extraintestinal pathogenic Escherichia coli

Activity of cefepime and carbapenems in experimental pneumonia caused by porin- deficient Klebsiella pneumoniae producing FOX-5 β-lactamase C. Pichardo,

Circulation of international clones of levofloxacin non-susceptible Streptococcus pneumoniae in Taiwan Y.-C. Hsieh, L.-Y. Chang, Y.-C. Huang, H.-C. Lin,

C. Gagliotti, L. Nobilio, M.L. Moro

Prevalence and diversity of extended-spectrum ß-lactamases in faecal Escherichia coli isolates from healthy humans in Spain L. Vinué, Y. Sáenz, S. Martínez,

Risk of acquiring multidrug-resistant Gram-negative bacilli from prior room occupants in the intensive care unit S. Nseir, C. Blazejewski, R. Lubret,

Correlation between time to positivity of blood cultures with clinical presentation and outcomes in patients with Klebsiella pneumoniae bacteraemia: prospective.

R. Cantón, A. Novais, A. Valverde, E. Machado, L. Peixe, F. Baquero, T

Statin use and clinical outcomes among pneumonia patients

Clinical Microbiology and Infection

I. Bitar, A. Piazza Clinical Microbiology and Infection

Antibiotic resistance patterns of more than clinical Escherichia coli isolates in Southeast Austria, 1998–2013 A. Badura, G. Feierl, G. Pregartner,

Results of two worldwide surveys into physician awareness and perceptions of extended-spectrum β-lactamases H. Goossens, S. Malhotra-Kumar, H. Eraksoy,

The atypical pneumonias: clinical diagnosis and importance

J.J. Keller, M.-C. Tsai, C.-C. Lin, Y.-C. Lin, H.-C. Lin

Predominance of SHV-5 β-lactamase in enteric bacteria causing community-acquired urinary tract infections in Bosnia and Herzegovina S. Uzunovic-Kamberovic,

Modelling during an emergency: the 2009 H1N1 influenza pandemic

New oral cephalosporins in pediatric community-acquired infections

Assessment of the usefulness of performing bacterial identification and antimicrobial susceptibility testing 24 h a day in a clinical microbiology laboratory

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

G. Kahlmeter Clinical Microbiology and Infection

Impact of antibiotic restrictions: the patient's perspective

CMI readers' survey Clinical Microbiology and Infection

The future of diagnostic bacteriology

Presentation transcript:

Long-term study of the frequency of Escherichia coli and Klebsiella pneumoniae isolates producing extended-spectrum β-lactamases L. Romero, L. López, J. Rodríguez-Baño, J. Ramón Hernández, L. Martínez-Martínez, A. Pascual Clinical Microbiology and Infection Volume 11, Issue 8, Pages 625-631 (August 2005) DOI: 10.1111/j.1469-0691.2005.01194.x Copyright © 2005 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 Comparison of the frequency of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae according to origin. (a) Frequency of ESBL-producing E. coli from inpatients and outpatients. (b) Frequency of ESBL-producing K. pneumoniae from inpatients and outpatients. Clinical Microbiology and Infection 2005 11, 625-631DOI: (10.1111/j.1469-0691.2005.01194.x) Copyright © 2005 European Society of Clinical Infectious Diseases Terms and Conditions